Is Generative AI The Future of Equitable Healthcare?
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Renal Cell Cancer, Recurrent
Also known as:
Recurrent Renal Cell Cancer
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB12442
Alvespimycin
1
Completed
1
DB01143
Amifostine
1
Completed
1
DB00928
Azacitidine
1
Completed
1
DB00112
Bevacizumab
1
Completed
1
DB11752
Bryostatin 1
1
Completed
1
DB00958
Carboplatin
1
Completed
1
DB00531
Cyclophosphamide
1
Terminated
1
DB15631
Edodekin alfa
1
Completed
1
DB01590
Everolimus
1
Completed
1
DB05304
Girentuximab
1
Completed
1
DB16024
Indocyanine green
1
Completed
1
DB00105
Interferon alfa-2b
1
Completed
1
DB14123
Menthol
1
Completed
2
DB15721
Natural Killer Cell
1
Completed
1
DB01229
Paclitaxel
1
Completed
1
DB11870
RG-4733
1
Completed
1
DB00877
Sirolimus
1
Completed
1
DB01268
Sunitinib
1
Completed
2
DB06287
Temsirolimus
1
Completed
3
DB00072
Trastuzumab
1
Completed
1
DB04879
Vatalanib
1
Completed
1
DB00361
Vinorelbine
1
Completed
1
DB00112
Bevacizumab
1 / 2
Completed
2
DB00112
Bevacizumab
1 / 2
Terminated
1
DB00091
Cyclosporine
1 / 2
Completed
3
DB12213
Etaracizumab
1 / 2
Terminated
1
DB01590
Everolimus
1 / 2
Terminated
1
DB01073
Fludarabine
1 / 2
Completed
3
DB15107
Fludeoxyglucose
1 / 2
Completed
1
DB09150
Fludeoxyglucose (18F)
1 / 2
Completed
1
DB00982
Isotretinoin
1 / 2
Terminated
1
DB00688
Mycophenolate mofetil
1 / 2
Completed
3
DB06603
Panobinostat
1 / 2
Terminated
1
DB06287
Temsirolimus
1 / 2
Completed
1
DB17459
Therapeutic allogeneic lymphocytes
1 / 2
Completed
1
DB02546
Vorinostat
1 / 2
Completed
1
DB02546
Vorinostat
1 / 2
Terminated
1
DB00041
Aldesleukin
2
Completed
1
DB15463
Belzutifan
2
Active Not Recruiting
1
DB11105
Benzalkonium
2
Completed
2
DB11105
Benzalkonium
2
Terminated
1
DB00112
Bevacizumab
2
Completed
1
DB11752
Bryostatin 1
2
Completed
1
DB08875
Cabozantinib
2
Active Not Recruiting
1
DB11960
Carboxyamidotriazole
2
Completed
1
DB04849
Cediranib
2
Terminated
1
DB00530
Erlotinib
2
Completed
1
DB01590
Everolimus
2
Terminated
1
DB14800
GP-100 antigen
2
Completed
1
DB17475
Incomplete Freund's adjuvant
2
Completed
1
DB05258
Interferon alfa
2
Completed
1
DB05258
Interferon alfa
2
Terminated
1
DB00034
Interferon alfa-2a
2
Completed
1
DB00034
Interferon alfa-2a
2
Terminated
1
DB00105
Interferon alfa-2b
2
Completed
2
DB00105
Interferon alfa-2b
2
Terminated
1
DB00018
Interferon alfa-n3
2
Completed
1
DB00018
Interferon alfa-n3
2
Terminated
1
DB06188
Ispinesib
2
Completed
1
DB04845
Ixabepilone
2
Completed
1
DB00526
Oxaliplatin
2
Completed
1
DB03010
Patupilone
2
Completed
1
DB06589
Pazopanib
2
Completed
1
DB06436
Semaxanib
2
Terminated
1
DB00398
Sorafenib
2
Completed
1
DB00398
Sorafenib
2
Terminated
2
DB05465
Tandutinib
2
Completed
1
DB01041
Thalidomide
2
Completed
1
DB16626
Tyrosinase
2
Completed
1
DB06589
Pazopanib
Not Available
Terminated
1
DB01268
Sunitinib
Not Available
Terminated
1